DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,081 | +2.8% | 4,360 | -0.5% | 0.06% | +7.7% |
| Q2 2023 | $1,052 | -14.8% | 4,380 | -10.6% | 0.05% | -13.3% |
| Q1 2023 | $1,235 | +1.8% | 4,902 | +4.4% | 0.06% | -20.0% |
| Q4 2022 | $1,213 | -99.9% | 4,695 | 0.0% | 0.08% | 0.0% |
| Q3 2022 | $1,213,000 | +13.3% | 4,695 | +11.2% | 0.08% | +25.0% |
| Q2 2022 | $1,071,000 | -12.8% | 4,221 | +0.8% | 0.06% | -4.8% |
| Q1 2022 | $1,228,000 | +14.1% | 4,188 | +28.0% | 0.06% | +18.9% |
| Q4 2021 | $1,076,000 | +8.0% | 3,273 | 0.0% | 0.05% | -8.6% |
| Q3 2021 | $996,000 | +81.4% | 3,273 | +59.9% | 0.06% | +65.7% |
| Q2 2021 | $549,000 | -4.5% | 2,047 | -19.9% | 0.04% | -12.5% |
| Q1 2021 | $575,000 | +1.2% | 2,555 | -0.2% | 0.04% | -4.8% |
| Q4 2020 | $568,000 | +2.2% | 2,559 | -1.0% | 0.04% | -12.5% |
| Q3 2020 | $556,000 | +61.6% | 2,586 | +32.8% | 0.05% | +60.0% |
| Q2 2020 | $344,000 | +41.6% | 1,948 | +10.9% | 0.03% | +15.4% |
| Q1 2020 | $243,000 | -5.4% | 1,756 | +4.6% | 0.03% | +13.0% |
| Q4 2019 | $257,000 | -7.2% | 1,678 | -12.7% | 0.02% | -17.9% |
| Q3 2019 | $277,000 | -0.7% | 1,923 | -1.6% | 0.03% | -6.7% |
| Q2 2019 | $279,000 | -16.5% | 1,954 | -22.8% | 0.03% | -21.1% |
| Q1 2019 | $334,000 | +53.2% | 2,530 | +19.6% | 0.04% | +22.6% |
| Q4 2018 | $218,000 | -31.9% | 2,115 | -43.6% | 0.03% | -61.2% |
| Q1 2017 | $320,000 | +24.0% | 3,751 | +46.8% | 0.08% | -15.8% |
| Q2 2016 | $258,000 | +4.5% | 2,556 | -1.9% | 0.10% | +2.2% |
| Q1 2016 | $247,000 | +2.1% | 2,606 | 0.0% | 0.09% | +3.3% |
| Q4 2015 | $242,000 | 0.0% | 2,606 | -8.5% | 0.09% | -13.5% |
| Q3 2015 | $242,000 | – | 2,847 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |